Newborn · NAS
Neonatal Abstinence Syndrome (NAS)
Newborn withdrawal from substances used in pregnancy. Finnegan score (21 items, ≥8 triggers treatment). Non-pharmacological first (quiet, swaddling, breastfeeding); morphine if needed. ESC newer approach. UK NICE / RCPCH.
Last reviewed 2 June 2026
Neonatal abstinence (withdrawal) severity
What is NAS?
Neonatal Abstinence Syndrome — withdrawal symptoms in newborn from substances used in pregnancy.
Most common cause: opioids (prescription, methadone, heroin, buprenorphine). Also: SSRIs, benzodiazepines, alcohol (FAS), nicotine, cannabis, cocaine.
Finnegan score
21 items across 3 categories:
- Neurological/CNS: high-pitched cry, tremors, increased tone, sleep disturbance, sneezing, yawning.
- Metabolic/vasomotor/respiratory: sweating, fever, fast breathing, mottling, nasal congestion.
- Gastrointestinal: excessive suck, poor feeding, regurgitation, loose stools.
Each item scored 0-5. Score ≥8 three times consecutively (or ≥12 once) usually triggers pharmacological treatment.
Symptom timing by substance
- Heroin: within 24h.
- Prescription opioids: 24-72h.
- Methadone: 24-72h; can delay to 5-7 days.
- Buprenorphine: 36-72h; usually milder.
- Alcohol: hours-days.
- SSRIs: hours; usually mild self-limiting.
- Benzodiazepines: 24h-7 days.
Monitor 5-7 days minimum; longer for methadone.
Treatment
- Non-pharmacological first: quiet, dim environment; swaddling; minimal handling; skin-to-skin; rooming-in; breastfeeding.
- Pharmacological: morphine first-line for opioid NAS; weaned over days-weeks.
- Second-line: phenobarbital, clonidine for non-opioid / refractory.
- Nutrition: small frequent feeds.
Breastfeeding with methadone / buprenorphine
Usually encouraged. Tiny amounts in milk; reduces NAS severity + hospital stay. Stops if: active street opioid use, HIV positive (UK), severe maternal illness.
Eat Sleep Console (ESC)
Newer approach. Assesses function: can baby EAT (1+ oz/feed), SLEEP (1+ hour), CONSOLE (within 10 min)? If yes across all three: no pharmacological needed.
Reduces hospital stay + medication exposure. Equally safe. AAP-supported alternative.
Long-term outlook
Most babies recover within weeks-months. Subtle differences in behaviour, attention, sleep, cognition possible — confounded by social factors. Early intervention key.
FAS (fetal alcohol syndrome)
Different from opioid NAS. Specific facial features, growth deficiency, CNS abnormalities. Lifelong condition. No safe alcohol level. NOFAS UK, FASD Support Network.
Different scenarios
Scenario 1: Mother on methadone maintenance, baby born to term
Specialist NAS team prepared. Rooming-in encouraged. Breastfeeding supported. Monitor 5-7 days minimum. Morphine if Finnegan ≥8.
Scenario 2: Baby born to SSRI-treated mum, mildly irritable
Mild self-limiting. Continue breastfeeding. Comfort measures. Usually resolves 1-2 weeks.
Scenario 3: Severe NAS, ESC approach
Assess EAT/SLEEP/CONSOLE every feed. If not meeting criteria, escalate care; pharmacological if needed.
Scenario 4: Maternal alcohol use disclosed late
Assess for FAS features. Long-term developmental follow-up regardless of acute symptoms.
Scenario 5: Multiple substances, complex social situation
Multi-agency: addiction, social work, neonatology, mental health. Safety + support plan. Possible CP plan.
Care guidance — NAS
- Non-pharm first; pharm if needed.
- Breastfeeding usually supported with maintenance treatment.
- ESC alternative reduces overtreatment.
- Specialist NAS team.
- Multi-agency support.
- Long-term developmental follow-up.
- NO judgment; focus on welfare.
- Recovery is possible.
Sources
- Finnegan LP, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975.
- NICE NG54. Drug misuse in over 16s.
- RCPCH. Neonatal abstinence syndrome guidance.
- AAP. Eat, Sleep, Console: alternative approach.